Your search for "vaccines" return 126 results.
Ceva acquires Sogeval >
Sogeval, a subsidiary of Sofiprotéol, joins veterinary firm Ceva Santé Animale with a view to creating one of the world leaders in veterinary pharmacy.
Ceva and Sogeval in exclusive negotiations to create a global leader in animal health >
Ceva and Sogeval (a subsidiary of Sofiprotéol), based in Laval announce the opening of exclusive negotiations to create a future alliance.
Long term agreement with Jinyu Baoling to produce brucellosis vaccines in China >
Ceva concludes long term agreement with Jinyu Baoling to produce brucellosis vaccines in China
Ceva launches new Vectormune ® website >
Website provides educational resources for poultry professionals, as well as comprehensive information about their vector vaccines range.
Ceva stresses the need for more INNOVATION in the hatchery to drive growing global demand for poultry meat >
Company launches Cevac IBird ® a live, attenuated IB vaccine, to add to its portfolio of 16 new technology vaccines
Ceva stresses the need for more INNOVATION in the hatchery to drive growing global demand for poultry meat >
Company launches Cevac IBird ® a live, attenuated IB vaccine, to add to its portfolio of 16 new technology vaccines
Ceva’s growth continues despite difficult market conditions >
Libourne, France, 22 July, 2013: Consolidated sales of the Ceva Group reached €310m in the first 6 months of 2013, up by 2%, 4.2% on the previous year at a constant perimeter and exchange rates. C...
Ceva signs a Joint-venture agreement in China to help control zoonoses >
Joint-venture with Jinyu Baoling will produce brucellosis vaccines in Inner Mongolia
Signature of a scientific collaboration protocol about avian influenza with South China Agricultural University >
Paris, May 29th 2013 1- Ceva, a socially responsible company committed to the well-being of the planet Ceva Santé Animale is a multi-national French based animal health company that counts over 3000 e...
Ceva uses creative thinking in new approach to innovation in Industrial equity >
Libourne, France 2nd May 2013: Most of the time innovation in the bio-pharmaceutical field is associated with the scientific R&D teams. But having the latest technology vaccines is of little value i...